ICON plc | Clinical Research Organisation (CRO) for Drug Development

Webinar: Effective Ingestion and Normalization of RWD Sources

Using Technology Advancements to Produce Powerful Real World Evidence (RWE)

Webinar: A Novel Approach to ALS Trial Development

Review insights on ALS studies and recruitment challenges involving newly diagnosed rare disease participants.

Personalising Digital Health Solutions

Develop digital health solutions to improve clinical R&D efficiency and patient outcomes

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

Featured Services

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data

Biosimilars

ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars.

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional Resourcing

From recruitment of a single clinical professional to managing entire global functions.

ICON Insights

14 January 2020

Changes in Clinical Safety Reporting to the FDA

FDA has upgrade the Investigational New Drug (IND) safety reporting from paper eCTD format to E2B format, improving potential safety signals in clinical studies

03 December 2019

Healthcare Resource Use and Costs in AML Patients Undergoing Stem Cell Transplantation

ISPOR EU 2019 WINNER - Best General Poster Research Presentations: Health Care Use and Costs in Acute Myeloid Leukaemia (AML) Patients Undergoing Stem Cell Transplantation.

27 November 2019

Innovation in Oncology Drug Development

Significant progress has been made in our understanding of the molecular lesions responsible for tumor cells to exhibit uncontrolled growth.

22 November 2019

Top Five Digital Technologies Set to Transform Pharma R&D

The current wave of emerging digital technologies offers an opportunity to significantly disrupt pharma business operating models in a variety of ways.

19 November 2019

The Impact of Digital Technology on Patient Engagement in Clinical Trials

The use of digital technology in clinical trials is creating more convenient, engaging and innovative treatments for patients

15 November 2019

Payers Report that ICER Analyses Increasingly Guide US Price Negotiations

According to a survey conducted by ICON in July 2019, prescription drug cost effectiveness analyses by the Institute for Clinical and Economic Review (ICER) are playing an increasingly important role in price negotiations.

14 November 2019

Four Challenges to Successful Rare Disease Drug Development

Overcoming these challenges can greatly improve chances for a successful rare or orphan drug trial.

01 November 2019

Harnessing Big Data: The raw material of digital transformation

The integration and mastery of digital technologies is becoming essential to improve the efficiency of clinical trial operations.

31 October 2019

Challenges and Advances in NASH Clinical Trials

NASH is massively under-diagnosed, partly because it is a silent disease and partly because definitive diagnosis is by histopathology of a liver biopsy with associated risks.

Services

Sectors

Therapeutics

Innovation

Insights

News & Events

About ICON

Reimagining Patient-Centric Clinical Trials with the IoMT

Developing medical communications specifically for nurses

How digital technologies will transform R&D productivity

Increasing complexity and declining ROI in drug development